India city Mumbai covid-19 pandemic India city Mumbai

GSK to sell $3.9 billion stake in HUL

Reading now: 452
www.livemint.com

MUMBAI : GlaxoSmithKline Plc (GSK) will soon begin selling its stake in Hindustan Unilever Ltd (HUL) estimated to be worth almost ₹29,850 crore ($3.9 billion), a person aware of the development said.

GSK received the shares earlier this month in return for the sale of its Indian consumer business to HUL. The two multinational giants had announced the all-share deal worth ₹31,700 crore ($3.8 billion) in December 2018.

Bloomberg first reported on Wednesday that GSK was in discussions with its advisers on when to launch the transaction. In a statement on 1 April, Glaxo said HUL has paid it an extra ₹3,045 crore (approximately $400 million) crore to acquire the Horlicks brand for India, after seeking approval from the board of HUL, exercising

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA